{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:23:09Z","timestamp":1776360189658,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Major Science and Technology Projects in Tianjin","award":["17ZXMFSY00160"],"award-info":[{"award-number":["17ZXMFSY00160"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802605"],"award-info":[{"award-number":["81802605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12325-021-01888-3","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T11:02:58Z","timestamp":1629716578000},"page":"5178-5190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis"],"prefix":"10.1007","volume":"38","author":[{"given":"Binkai","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4631-4115","authenticated-orcid":false,"given":"Yuanjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"issue":"2","key":"1888_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0015-0282(16)48729-7","volume":"44","author":"CL Schmidt","year":"1985","unstructured":"Schmidt CL. Endometriosis: a reappraisal of pathogenesis and treatment. Fertil Steril. 1985;44(2):157.","journal-title":"Fertil Steril"},{"issue":"9","key":"1888_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045223","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Che X, Zhu L, Zhao M, Fu G, Huang X, Xu H, Hu F, Zhang X. Pigment epithelium derived factor inhibits the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro. PLoS ONE. 2012;7(9): e45223.","journal-title":"PLoS ONE"},{"issue":"1","key":"1888_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/mmr.2013.1755","volume":"9","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Higashiura Y, Shigetomi H, Kajihara H. Pathogenesis of endometriosis: the role of initial infection and subsequent sterile inflammation (review). Mol Med Rep. 2014;9(1):9\u201315.","journal-title":"Mol Med Rep"},{"issue":"25","key":"1888_CR4","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","volume":"362","author":"LC Giudice","year":"2010","unstructured":"Giudice LC. Endometriosis. N Engl J Med. 2010;362(25):2389\u201398.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1888_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000052874","volume":"50","author":"M Nishida","year":"2000","unstructured":"Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest. 2000;50(Suppl 1):18\u201325.","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"1888_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00004347-199601000-00001","volume":"15","author":"JD Seidman","year":"1996","unstructured":"Seidman JD. Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol. 1996;15(1):1\u20139.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"1888_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejogrb.2007.06.017","volume":"138","author":"H Kobayashi","year":"2008","unstructured":"Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Terao T. Ovarian endometrioma\u2014risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol. 2008;138(2):187\u201393.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"1888_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10147-009-0935-y","volume":"14","author":"M Mandai","year":"2009","unstructured":"Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 2009;14(5):383\u201391.","journal-title":"Int J Clin Oncol"},{"key":"1888_CR9","doi-asserted-by":"crossref","unstructured":"Guidozzi F. Endometriosis-associated cancer. Climacteric. 2021;1\u20136.","DOI":"10.1080\/13697137.2021.1948994"},{"key":"1888_CR10","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. IARC; 2014."},{"issue":"4","key":"1888_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih I. The dualistic model of ovarian carcinogenesis. Am J Pathol. 2016;186(4):733\u201347.","journal-title":"Am J Pathol"},{"issue":"5","key":"1888_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10552-017-0856-4","volume":"28","author":"EM Poole","year":"2017","unstructured":"Poole EM, Lin WT, Kvaskoff M, De Vivo I, Terry KL, Missmer SA. Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control. 2017;28(5):437\u201345.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"1888_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1067\/mob.2003.408","volume":"189","author":"RB Ness","year":"2003","unstructured":"Ness RB. Endometriosis and ovarian cancer: Thoughts on shared pathophysiology. Am J Obstet Gynecol. 2003;189(1):280\u201394.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1888_CR14","first-page":"788","volume":"100","author":"SC Modesitt","year":"2002","unstructured":"Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol. 2002;100(4):788\u201395.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"1888_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/jog.13372","volume":"43","author":"F Taniguchi","year":"2017","unstructured":"Taniguchi F. New knowledge and insights about the malignant transformation of endometriosis. J Obstet Gynaecol Res. 2017;43(7):1093\u2013100.","journal-title":"J Obstet Gynaecol Res"},{"key":"1888_CR16","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8730","volume":"8","author":"L Jiang","year":"2020","unstructured":"Jiang L, Zhang M, Wang S, Han Y, Fang X. Common and specific gene signatures among three different endometriosis subtypes. PeerJ. 2020;8: e8730.","journal-title":"PeerJ"},{"key":"1888_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0578-1","author":"J Shen","year":"2019","unstructured":"Shen J, Yu S, Sun X, Yin M, Fei J, Zhou J. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis. J Ovarian Res. 2019. https:\/\/doi.org\/10.1186\/s13048-019-0578-1.","journal-title":"J Ovarian Res"},{"key":"1888_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-0613-2","author":"D Yang","year":"2020","unstructured":"Yang D, He Y, Wu B, Deng Y, Wang N, Li M, Liu Y. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. J Ovarian Res. 2020. https:\/\/doi.org\/10.1186\/s13048-020-0613-2.","journal-title":"J Ovarian Res"},{"key":"1888_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","volume":"75","author":"P Nordlund","year":"2006","unstructured":"Nordlund P, Reichard P. Ribonucleotide reductases. Annu Rev Biochem. 2006;75:681\u2013706.","journal-title":"Annu Rev Biochem"},{"issue":"16","key":"1888_CR20","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1016\/S0021-9258(17)39337-7","volume":"260","author":"Y Engstrom","year":"1985","unstructured":"Engstrom Y, Eriksson S, Jildevik I, Skog S, Thelander L, Tribukait B. Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem. 1985;260(16):9114\u20136.","journal-title":"J Biol Chem"},{"issue":"2","key":"1888_CR21","first-page":"141","volume":"1805","author":"E Furuta","year":"2010","unstructured":"Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: Their roles in tumor progression and clinical implications. Biochim Biophys Acta. 2010;1805(2):141\u201352.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1888_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/156800906777723949","volume":"6","author":"J Shao","year":"2006","unstructured":"Shao J, Zhou B, Chu B, Yen Y. Ribonucleotide reductase inhibitors and future drug design. Curr Cancer Drug Targets. 2006;6(5):409.","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"1888_CR23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2013.03.004","volume":"3","author":"KM Aird","year":"2013","unstructured":"Aird KM, Zhang G, Li H, Tu Z, Bitler BG, Garipov A, Wu H, Wei Z, Wagner SN, Herlyn M, Zhang R. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 2013;3(4):1252\u201365.","journal-title":"Cell Rep"},{"issue":"8","key":"1888_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/sj.onc.1207272","volume":"23","author":"MS Duxbury","year":"2004","unstructured":"Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Oncogene. 2004;23(8):1539\u201348.","journal-title":"Oncogene"},{"issue":"5","key":"1888_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00535-007-2017-0","volume":"42","author":"T Itoi","year":"2007","unstructured":"Itoi T, Sofuni A, Fukushima N, Itokawa F, Tsuchiya T, Kurihara T, Moriyasu F, Tsuchida A, Kasuya K. Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas. J Gastroenterol. 2007;42(5):389\u201394.","journal-title":"J Gastroenterol"},{"issue":"1","key":"1888_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2006.12.177","volume":"354","author":"MS Duxbury","year":"2007","unstructured":"Duxbury MS, Whang EE. RRM2 induces NF-\u03baB-dependent MMP-9 activation and enhances cellular invasiveness. Biochem Biophys Res Commun. 2007;354(1):190\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1888_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3816\/CCC.2007.n.007","volume":"6","author":"X Liu","year":"2007","unstructured":"Liu X, Zhou B, Xue L, Yen F, Chu P, Un F, Yen Y. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer. Clin Colorectal Cancer. 2007;6(5):374\u201381.","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"1888_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1476-4598-8-11","volume":"8","author":"K Zhang","year":"2009","unstructured":"Zhang K, Hu S, Wu J, Chen L, Lu J, Wang X, Liu X, Zhou B, Yen Y. Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis. Mol Cancer. 2009;8(1):11.","journal-title":"Mol Cancer"},{"issue":"10","key":"1888_CR29","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/sj.bjc.6604344","volume":"98","author":"J Souglakos","year":"2008","unstructured":"Souglakos J, Boukovinas I, Taron M, Mendez P, Mavroudis D, Tripaki M, Hatzidaki D, Koutsopoulos A, Stathopoulos E, Georgoulias V, Rosell R. Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel\/gemcitabine. Br J Cancer. 2008;98(10):1710\u20135.","journal-title":"Br J Cancer"},{"issue":"14","key":"1888_CR30","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-18-4046","volume":"25","author":"YZ Mazzu","year":"2019","unstructured":"Mazzu YZ, Armenia J, Chakraborty G, Yoshikawa Y, Coggins SA, Nandakumar S, Gerke TA, Pomerantz MM, Qiu X, Zhao H, Atiq M, Khan N, Komura K, Lee GM, Fine SW, Bell C, O\u2019Connor E, Long HW, Freedman ML, Kim B, Kantoff PW. A novel mechanism driving poor-prognosis prostate cancer: Overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2). Clin Cancer Res. 2019;25(14):4480\u201392.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1888_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4161\/cc.26953","volume":"13","author":"KM Aird","year":"2013","unstructured":"Aird KM, Li H, Xin F, Konstantinopoulos PA, Zhang R. Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. Cell Cycle. 2013;13(2):199\u2013207.","journal-title":"Cell Cycle"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01888-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T08:59:44Z","timestamp":1632819584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01888-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1888"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01888-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"9 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}